课题基金 / 基金详情

A thyroid receptor co-activator hypothesis for psychosis

A thyroid receptor co-activator hypothesis for psychosis
精神病的甲状腺受体共激活剂假说
批准号:
6419797
负责人:
Robert A Philibert
金额:
$17.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-01 至 2005-12-31

项目摘要

项目成果

Robert A Philibert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) Schizophrenia is a neurodevelopmental syndrome that affects approximately 1 percent of the U.S. population and is characterized by the presence of hallucinations and delusions. Genetic factors are thought to account for the majority of the vulnerability to illness for this syndrome. These genetic factors are thought to be composed of major, moderate ant mild effect loci. The identification and characterization of genetic factors of even mild effect loci is a critical step in the process of understanding the pathogenesis of this group of disorders. In prior moleular studies, the candidate has identified an exonic polymorphism (HOPA12bP) in a critical portion of a gene for a thyroid receptor co-activator named HOPAthat is associated with a behavioral endophenotype that include schizophrenia and hypothyroidism. In this five year training grant, the candidate proposes to focus on the behavioral syndrome that is associated with the polymorphism and 1) demonstrate segregation of the polymorphism with illness. 2 refine the phenotype associated with the polymorphism, and 3) identify other mutations that may be related to illness. Scientific Aims of this grant are 1). Peform case control analyses on schizophrenic probands with the HOPA12bp polymorphism. Schizophrenic HOPA probands will be identified and compared to matched case controls for cognitive/behavioral, endocrinological and medical differences. 2. Conduct a focused linkage study of the families of HOPA12bp probands. Structured interviews will be used to assess the presence of cognitive/behavioral and medical co-morbidity in the first-degree relatives of control and HOPA12bP probands. These results will be correlated with genetic status. 3). Conduct SSCP analysis across the HOPA Gene to detect other potentially pathogenic mutations. Mutation analysis will be performed using DNA from other schizophrenic patients to detect other mutations in theHOPA gene that can result in result in this syndrome or related phenotypes. Training Aims of this grant are to 1) develop clinical skills in the diagnosis and standardized measurement of complex behavior and endocrinological disorders, and 2) learn medical and psychiatric epidemiology, ethics, and biostatistical approaches to complex disorders. The net effect will be to produce an independent investigator capable of functional and translational research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Saliva Based Epigenetic Assay for Assessing Vitamin B9 and B12 Status
  • 批准号:
    10541702
  • 项目类别:
  • 资助金额:
    $28.14万
  • 财政年份:
    2022
  • 负责人:
    Robert A Philibert
  • 依托单位:
A DNA Methylation Test for Guiding Lung Cancer Screening
  • 批准号:
    10242473
  • 项目类别:
  • 资助金额:
    $39.56万
  • 财政年份:
    2021
  • 负责人:
    Robert A Philibert
  • 依托单位:
Quantitative Biomarkers for Monitoring Alcohol Abstinence
  • 批准号:
    9752723
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2019
  • 负责人:
    Robert A Philibert
  • 依托单位:
A Saliva Based Kit for the Epigenetic Assessment of Heavy Alcohol Intake
  • 批准号:
    9680049
  • 项目类别:
  • 资助金额:
    $22.33万
  • 财政年份:
    2018
  • 负责人:
    Robert A Philibert
  • 依托单位:
海外基金